Nucor Corporation heads into the back half of August with an unusual split: the stock has put in a strong month, yet options traders just flashed the most defensive signal in more than a year.
The options story is the most striking development this week. The put/call ratio jumped to 0.77 on August 14 — more than four standard deviations above its 20-day mean of 0.61, easily the most elevated reading of the past year and approaching the 52-week high of 0.81. That kind of z-score (4.2) is rare, and it points to a sharp, sudden demand for downside protection rather than a gradual drift in sentiment. It landed against a backdrop where the stock slipped 1.4% on the week to $268.91, after a 14.8% run over the prior month that took NUE well clear of its spring lows.
The lending market tells a completely different story — one of almost no short-side pressure at all. Availability is effectively unlimited, with over 186 million shares in the lending pool relative to just 3.7 million shorted. Short interest at 1.6% of the free float is at its lowest point in roughly six weeks, having fallen 8% over the past month and 7.9% over the past week alone. Cost to borrow is 0.41%, technically up sharply from a near-zero blip on August 10, but the directional move is noise — the absolute level remains trivially cheap. Bears who want to press the short side face no structural impediment; there simply are not many who have chosen to.
The Street leans constructive, though valuation is catching up to the thesis. Following Nucor's July 28 earnings report, multiple firms lifted targets: Barclays raised to $295 from $272, Wells Fargo moved to $297 from $283, and BMO Capital went to $295 from $285. UBS, the notable holdout at Neutral, still lifted its target to $256 from $224. The mean price target across the analyst community is $283.56 — about 5% above the current price — which is tighter than it looked a month ago. The PE multiple has expanded by 0.68 turns over 30 days to 14.5x, and EV/EBITDA has drifted slightly lower to 8.9x as earnings estimates moved up. Factor scores support the bull case on momentum — EPS momentum ranks in the 84th percentile on a 30-day basis and the 87th over 90 days — though forward EPS growth on a year-on-year basis scores only in the 26th percentile, the one soft spot.
Recent earnings reactions have been a tailwind rather than a risk. The last three prints produced next-day gains of roughly 0.5%, 3.3%, and 7.3%, with five-day follow-through of 6.2%, 10.6%, and 5.5% respectively. The pattern is consistently positive, suggesting the market has been rewarding rather than fading Nucor's results. The next event is not until November 5, so earnings are not the near-term catalyst.
Insider activity is worth a footnote. Net selling has dominated recent weeks — the President/COO sold roughly $1 million in late July, and an EVP sold a further $1 million on August 3. On a 90-day net basis, though, the balance is modestly positive in share terms (around 70,000 shares net), meaning the recent sells are not bucking a broader insider-buying trend so much as routine executive monetisation. Peer comparison confirms the sector softness: closest peer STLD fell 2.5% on the week, CLF dropped 2.9%, and CMC shed 4.7%, so NUE's 1.4% decline is actually relative outperformance within a weak tape for steel names.
The disconnect between a tight options positioning print and a completely relaxed lending market is the tension worth tracking — whether the put-call spike reflects genuine hedging ahead of a macro catalyst or simply a one-day positioning artefact will become clearer as the week's data rolls in.
See the live data behind this article on ORTEX.
Open NUE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
